Abrams P - Search Results

1

A consensus statement on when to start clean intermittent self-catheterization: An untapped resource?

Chapple C, Abrams P, Lam T, Mangera A, Belal M, Curtis C, Emkes J, Hillery S, Irwin K, Logan K, Weston P, Yates A. Chapple C, et al. Among authors: abrams p. Neurourol Urodyn. 2024 Feb;43(2):459-463. doi: 10.1002/nau.25353. Epub 2023 Dec 11. Neurourol Urodyn. 2024. PMID: 38078751

2

Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base.

Gacci M, Sebastianelli A, Spatafora P, Corona G, Serni S, De Ridder D, Gravas S, Abrams P. Gacci M, et al. Among authors: abrams p. Ther Adv Urol. 2017 Dec 7;10(2):79-92. doi: 10.1177/1756287217742837. eCollection 2018 Feb. Ther Adv Urol. 2017. PMID: 29434675 Free PMC article. Review.

3

FAQs: lower urinary tract symptoms in men.

Belal M, Abrams P. Belal M, et al. Among authors: abrams p. Practitioner. 2004 Sep;248(1662):652, 654, 656 passim. Practitioner. 2004. PMID: 15376550 No abstract available.

4

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Abrams P, et al. Br J Pharmacol. 2006 Jul;148(5):565-78. doi: 10.1038/sj.bjp.0706780. Epub 2006 Jun 5. Br J Pharmacol. 2006. PMID: 16751797 Free PMC article. Review.

5

Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach.

Belal M, Abrams P. Belal M, et al. Among authors: abrams p. J Urol. 2006 Jul;176(1):22-8. doi: 10.1016/S0022-5347(06)00569-6. J Urol. 2006. PMID: 16753359 Review.

6

Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 2: Noninvasive urodynamics and combination of measures.

Belal M, Abrams P. Belal M, et al. Among authors: abrams p. J Urol. 2006 Jul;176(1):29-35. doi: 10.1016/S0022-5347(06)00570-2. J Urol. 2006. PMID: 16753360

7

Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.

Abrams P, Cardozo L, Chapple C, Serdarevic D, Hargreaves K, Khullar V; 1032 Study Group. Abrams P, et al. Int J Urol. 2006 Jun;13(6):692-8. doi: 10.1111/j.1442-2042.2006.01387.x. Int J Urol. 2006. PMID: 16834644 Clinical Trial.

8

Does the patient's position influence the detection of detrusor overactivity?

Al-Hayek S, Belal M, Abrams P. Al-Hayek S, et al. Among authors: abrams p. Neurourol Urodyn. 2008;27(4):279-86. doi: 10.1002/nau.20503. Neurourol Urodyn. 2008. PMID: 17724734 Review.

9

Lower urinary tract symptoms revisited: a broader clinical perspective.

Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT, Roehrborn CG. Chapple CR, et al. Among authors: abrams p. Eur Urol. 2008 Sep;54(3):563-9. doi: 10.1016/j.eururo.2008.03.109. Epub 2008 Apr 8. Eur Urol. 2008. PMID: 18423969 Review.

10

Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.

Chapple C, Herschorn S, Abrams P, Sun F, Brodsky M, Guan Z. Chapple C, et al. Among authors: abrams p. Eur Urol. 2009 Sep;56(3):534-41. doi: 10.1016/j.eururo.2008.11.026. Epub 2008 Nov 24. Eur Urol. 2009. PMID: 19070418 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

695 results

Search Page